Submit Manuscript now
Impact Factor 2.6

Month: March 2022

Intestinal Congenital Fibrosarcoma Revealed by Intestinal Occlusion in A Three Months Old Child: Report of an Exceptional Case

Leave a Comment / Issue 1 Articles, Volume 8 / By

1. Abstract The congenital infantile Fibrosarcoma (IFS) is a rare non rhabdomyosarcoma malignancy diagnosed early at bird or first years of new born life. The intestinal location of this malignancy is exceedingly rare.no specific clinical or radiological nor histological signs can lead to diagnosis. The ETV6-NTRK3 fusion transcript is characteristic molecular signature of this tumor, …

Intestinal Congenital Fibrosarcoma Revealed by Intestinal Occlusion in A Three Months Old Child: Report of an Exceptional Case Read More »

Idiopathic Liver Abscess Through Pseudomonas Aeruginosa and Bacteroides Fragilis in A Covid-19 Patient

Leave a Comment / Issue 1 Articles, Volume 8 / By

1. Abstract 1.1. Background & Aims: SARS-CoV-2 is well known to cause respiratory diseases and hyperinflammation – but it may also affect other organs like the brain, liver and heart. Different case reports have shown the possibility of an abscess emerged through COVID-19, but until now, none has been reported to be localized in the …

Idiopathic Liver Abscess Through Pseudomonas Aeruginosa and Bacteroides Fragilis in A Covid-19 Patient Read More »

Irritable Bowel or Irritable Brain? Cognitive Behavioral Therapy for Irritable Bowel Syndrome: A Review and Recommendations for Clinical Practice

Leave a Comment / Issue 1 Articles, Volume 8 / By

1. Abstract Irritable bowel syndrome [IBS] is a chronic gastrointestinal disorder commonly seen in general practice. IBS has been described as a disturbance of the brain-gut axis where psychological stressors, such as stressful life events and anxiety, may affect the onset and development of this condition. Despite the availability of different management options, current treatments …

Irritable Bowel or Irritable Brain? Cognitive Behavioral Therapy for Irritable Bowel Syndrome: A Review and Recommendations for Clinical Practice Read More »

What Our Author Say's

I am glad that I found this platform. It was easy to get my research published and I was guided at every step. I highly recommend them.
Shuang-Qin Yi
am grateful to the Japanese Journal of Gastroenterology and Hepatology for helping me with my research and publishing it. Looking forward to more work with them.
Makki Fayadh
It has been a pleasure working with the Japanese Journal of Gastroenterology and Hepatology. They have been amazing in helping me with my manuscript
Han Min
I am glad that I submitted my manuscript here. They helped me make necessary edits and published the best version of it. I highly recommend them.
Sadaf Saleem

FAQ's About Jajgastrohepto

The Japanese Journal of Gastroenterology and Hepatology accepts all kinds of manuscripts, such as research, studies, reviews, clinical images, editorials, commentaries, etc.

For Detailed quotations reach out submission@jajogh.jp

It depends on the length of the manuscript and the reviews and edits needed.

We will help you with as many reviews and edits as are required to make your manuscript perfect for publication.

A good impact factor for JJGH is 2.0 as per Journal Citations Reports of 2021.

Niigata, 7F Stork Building Kagamibashi, 1230-7, 7-bancho, Kamiookawamaedori, Chuo-ku, Niigata, 951-8068, Japan.

*2021 Journal unofficial Impact Factor was established by dividing the number of articles published in 2020 with the number of times they are cited in 2021 based on Google Scholar Citation Index database. If ‘X’ is the total number of articles published in 2020 and ‘Y’ is the number of times these articles were cited in indexed journals during 2021 then, journal impact factor = Y/X.

Copyright 2018-2024 All Rights Reserved.